A2RL
23.4.2024 17:55:33 CEST | Business Wire | Press release
On Saturday, April 27th, Abu Dhabi will host a groundbreaking event, welcoming 10,000 spectators to witness the inaugural ASPIRE Abu Dhabi Autonomous Racing League (A2RL) at the iconic Yas Marina Circuit. This brand-new autonomous racing competition marks a significant milestone in motorsport history, billed as the largest league of its kind globally.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240423980323/en/
Making History: ASPIRE to Launch Inaugural ‘Abu Dhabi Autonomous Racing League’ Redefining Future of Extreme Sport on April 27 (Photo: AETOSWire)
Eight teams will compete: Code19 Racing (one of the first independent autonomous racing entity from the USA), Constructor University (based in Germany and Switzerland), Fly Eagle (representing Beijing Institute of Technology from China and Khalifa University from the UAE), HUMDA Lab (a member of the Széchenyi István University Group from Hungary), KINETIZ (a collaboration between Singapore Nanyang Technological University and Kintsugi based in the UAE), PoliMOVE (representing Politecnico di Milano from Italy), UNIMORE (also from Italy - University of Modena and Reggio Emilia), and Technical University of Munich - TUM (from Germany), vying for a substantial prize purse of US$ 2.25 million.
The participating teams of coders and engineers will each have exclusive access to identical Dallara Super Formula SF23 cars, made possible through a partnership with Japan Race Promotions. These cars will be autonomized with autonomous racing stacks developed and integrated by the Technology Innovation Institute (TII). The sole variable lies in how each team utilizes their coding skills, AI algorithms, and machine learning software development expertise to teach their cars how to drive. Currently recognized as the fastest open-wheel race car in the world after Formula One, these cars can reach speeds of up to 300 km/h.
For the first time, the race format is poised to feature four autonomous cars driving on the racetrack simultaneously – a feat never before attempted. In a series of pre-qualifying races, the finale will showcase the top performers from the Lap Test and Speed Test, advancing to a final Overtaking Challenge to determine the ultimate winner. Additionally, an AI vs Human car race will unfold, with the Technology Innovation Institute (TII) embracing the electrifying challenge of pitting their autonomous car against former F1 driver – Daniil Kvyat. TII will aim to get as close as possible to the human lap time and will also demonstrate the autonomous car’s ability to drive without GPS assistance.
H.E. Faisal Al Bannai, Secretary General of the Advanced Technology Research Council - ASPIRE’s parent entity, and Advisor to the UAE President on Strategic Research and Advanced Technology Affairs, said: "In pushing the boundaries of technology under extreme conditions, we uncover new frontiers in science. This reimagined racing paradigm harnesses the pinnacle of coding skills, AI algorithms, and software development prowess — the very skill sets of the future. By leveraging these capabilities, we pave a path at the forefront of research and development, propelling Abu Dhabi to become a pivotal global hub for innovation."
ADNOC has come on board as title sponsor, providing crucial support, underscoring the widespread enthusiasm for advancing autonomous racing technology. H.E. Dr. Sultan Al Jaber, Minister of Industry and Advanced Technology, and Group MD & CEO of ADNOC, added: "As we navigate the path to UAE's industrial future, our commitment to in-country value and technological advancement stands unwavering. A2RL epitomizes our dedication to integrating cutting-edge technology including AI, driving competitiveness and economic growth across sectors. For decades, ADNOC has invested in the latest technology and innovation – from the control room, to the board room - to deliver the modern energy that powers our lives."
Organizer of A2RL, ASPIRE CEO Stephane Timpano said: "A2RL is more than just a race — it's a platform for testing and optimizing autonomous vehicle technologies, enhancing safety and reliability on public roads. With the support of local and international partners, we're bringing the mobility future - closer." The inaugural race has attracted a diverse array of sponsors, each contributing their expertise and resources to ensure the success of the development of the cutting-edge autonomized cars. Leading partners, such as Du, DMT, AWS, and Mubadala, have played pivotal roles in shaping the event’s trajectory, with media partners such Motorsports, Inc. Arabia, FastCompany Middle East, and What’s On, amplifying A2RL’s visibility.
Technical partners, including Dallara, Danisi Engineering, Meccanica 42, Kistler, Seyond, Eventagrate, Live in Five, Focal Point VR and Vislink, have lent their specialized knowledge to elevate the event's innovation and performance standards.
An exclusive Fan Zone promises an elevated experience for families, motorsport fans, and tech enthusiasts alike. With tailored activities, guests can immerse themselves in cutting-edge tech and gaming, including a captivating VR zone and the AI museum – Raceum. From 16:00 (GST) on April 27, young students from the A2RL STEM Competition will showcase their coding skills on 1:8 scale autonomous racing cars, with 18 schools competing to add excitement. The night concludes at 23:00 (GST), with activities including a podium ceremony for the winners, fireworks, a drone show, and an after-show concert with DJ Andre Soueid.
For those unable to attend in person, the excitement of Race Day will be accessible through various live streaming channels, including A2RL’s official YouTube and Twitch channels, motorsport.tv and the A2RL app. Interested parties are invited to visit the A2RL website and monitor social media channels for updates regarding the program schedule and details on viewing the race in their respective regions.
The inaugural A2RL event is part of Abu Dhabi Mobility Week, running from April 24 to May 1.
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240423980323/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4*12.11.2026 23:07:00 CET | Press release
The multi-level takeover includes a Throne Room, interactive photo opportunities, special lighting, and more The Empire State Building (ESB) is the gateway to Mount Olympus in Percy Jackson’s world, and now fans can experience the magic like never before. On Nov. 16, the Empire State Building Observation Deck (ESBOD) will unveil “Olympus Awaits,” a multi-level “Percy Jackson and the Olympians” takeover, in partnership with Disney+. The immersive takeover – included with every Observation Deck ticket – will feature an epic Throne Room, interactive photo opportunities, surprise giveaways, ESB x “Percy Jackson” merch, and more, available through Dec. 4, 2026.* This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112442266/en/ Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4* “This immersive NYC experience
Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application12.11.2026 18:09:00 CET | Press release
Veristat’s InStat™ delivers submission-ready tables, listings, and figures (TLFs) in one week using validated statistical engines, shortening the critical path from database lock to submission VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced that it has partnered with Clene Nanomedicine to cut the time to deliver biostatistical outputs for a pivotal ALS drug application submission by 80%. Veristat reduced the time from study data to validated tables, listings and figures (TLFs) from up to six weeks to just one week. Clene, a late-stage biotech company, leveraged Veristat’s recently launched InStat™ platform, the industry’s first zero-code, fully automated solution to accelerate clinical trial processes. Biostatistical TLFs sit on the critical path for submissions, yet most sponsors rely on antiquated processes that involve slow, manual workflows to produce them, making post-database lock one of the biggest bottlenecks
WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network12.11.2026 18:00:00 CET | Press release
New feature lets members follow friends and family, share performance and health insights, and celebrate life's moments together WHOOP, the human performance brand, today launched WHOOP Humans, a new feature that lets members follow friends and family, share fitness, health, and performance data they choose, and support each other's progress. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112176779/en/ WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network For more than a decade, WHOOP has helped members better understand their own health and performance. Now, WHOOP Humans extends that experience beyond the individual, making it easier to celebrate achievements, encourage progress, and look out for the people who matter most. "In a world that's becoming increasingly artificial, we're building something deeply human,” said Will Ahmed, Founder and CEO of WHOOP. “This is the most verifiably human network ever
Integrated Hubs for Green Chemistry Research Aim to Transform How Chemicals and Materials Are Designed12.11.2026 17:00:00 CET | Press release
International network will investigate fundamental principles for creating safer, higher-performing chemicals and materials The Gordon and Betty Moore Foundation today announced four Integrated Research Hubs to explore new frontiers in chemical design, from materials that respond to their surroundings to molecules designed for safety from the start. Bringing together global researchers across institutions and disciplines, the hubs will investigate fundamental principles that could enable new capabilities in chemicals and materials while improving performance and protecting human health and the environment. The research priorities emerged through extensive engagement with the scientific community to identify the questions that could transform what chemistry can achieve. Each hub will connect researchers across institutions around one of four green chemistry focus areas: Safer molecular design: Led by The George Washington University, this hub will combine artificial intelligence and qua
Roquette Highlights Scalable Excipient and Capsule Solutions for Regional and Global Pharmaceutical Markets at CPHI India 202612.11.2026 16:00:00 CET | Press release
Helping pharmaceutical manufacturers accelerate the journey from formulation to market through deep technical expertise, meaningful innovation, close collaboration and global capabilities Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical excipients, will showcase its comprehensive portfolio of excipient and capsule solutions at CPHI India 2026, Hall 1, Booth 1I12 from November 23 to 25, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112803410/en/ Meet Roquette at CPHI India 2026, Hall 1, Booth 1I12 At the event, Roquette will demonstrate how it helps pharmaceutical manufacturers accelerate the journey from formulation to market with confidence. By combining technical expertise, trusted quality, meaningful innovation and close collaboration, Roquette helps customers address formulation, scale-up and manufacturing challenges across a broad range of pharmaceutical application
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
